Conmed (Conmed) EPS (Basic)

: $2.11 (TTM As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

Conmed's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was $1.08. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.11.

Conmed's EPS (Diluted) for the three months ended in Dec. 2023 was $1.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.04.

Conmed's EPS without NRI for the three months ended in Dec. 2023 was $1.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 2.85.

During the past 3 years, the average EPS without NRI Growth Rate was 120.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Conmed's highest 3-Year average EPS without NRI Growth Rate was 221.60% per year. The lowest was -56.90% per year. And the median was 7.85% per year.

Conmed EPS (Basic) Historical Data

The historical data trend for Conmed's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

1.01

0.33

2.14

-2.68

2.10

Conmed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)																0.87	0.06	0.45	0.52	1.08

Conmed EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Conmed's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(64.459	-	0)	/	30.668
	=	2.10

Conmed's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(33.071	-	0)	/	30.758
	=	1.08

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.11

Conmed (NYSE:CNMD) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Conmed EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Conmed's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Conmed (Conmed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (NYSE:CNMD) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

EC8:Germany

Address

11311 Concept Boulevard, Largo, FL, USA, 33773

Website

https://www.conmed.com

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Executives

Peters Stanley W Iii	officer: VP GM General Surgery	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Todd W. Garner	officer: Executive Vice President & CFO	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Edward A. Clifford	officer: VP Global Manufacturing	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Curt R Hartman	director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John D. Ferrell	officer: Executive Vice President - HR	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Brian Concannon	director	HAEMONETICS CORP, 400 WOOD RD, BRAINTREE MA 02184-9144
Peter K Shagory	officer: EVP,STRAT & CORP DEVT	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Daniel Jonas	officer: Vice President/Legal Affairs, other: General Counsel	C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Terence M Berge	officer: VP Corp. Treasurer	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Johonna Marie Pelletier	officer: Treasurer and VP, Tax	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Jerome J. Lande	director	1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
Brent Lalomia	officer: Vice President QA and RA	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John Jed Kennedy	officer: VP GM GI	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Mark E Tryniski	director	C/O CONMED CORP., 11311 CONCEPT BOULEVARD, LARGO FL 33773
Pat Beyer	officer: President-Conmed International	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773